Clinical Trial

PERL Study

About The PERL Study

A Multi-Center Clinical Trial of Allopurinol to Prevent Renal Function (GFR) Loss in Type 1 Diabetes

The purpose of this study is to find out whether a medication called allopurinol can prevent kidney problems, in particular, the loss of kidney function, in people with type 1 diabetes.

Recruitment

This study is no longer recruiting.

Contact

Dr. Allesandro Doria

Principal Investigator: Dr. Allesandro Doria
CHS(#2013-19)